Stocks Consumer discretionary ASTH
NASDAQ · Consumer discretionaryAstrana Health, Inc. (ASTH)
Astrana Health, Inc. brought in $3.9B of revenue over the twelve months to September 30, 2026, up 35.1% from a year earlier. Net income was $53.1M, a net margin of 1.4%. Operating cash flow minus capital spending left $104.5M of free cash flow in fiscal 2025. At September 30, 2026 it held $396.2M in cash against $925.4M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 6, 2026.
Key facts about Astrana Health, Inc.
- Net worth
- Astrana Health, Inc. has a market value (market cap) of $1.6B at the latest share price, and shareholders' equity of $856.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $3.2B (+56.4% year on year), with net income of $22.5M. Over the 12 months to September 30, 2026: revenue $3.9B, net income $53.1M.
- Cash flow
- In fiscal 2025 operations brought in $114.6M of cash; after $10.1M of capital spending, free cash flow was $104.5M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 6, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Astrana Health, Inc.'s next report is expected around March 1, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Astrana Health, Inc. does
Astrana Health, Inc. is registered with the SEC under industry code SIC 8742 (Services-Management Consulting Services). Its shares trade on NASDAQ under the ticker ASTH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $3.2B | $22.5M | $0.46 | $104.5M |
| 2024 | $2B | $43.1M | $0.90 | $44.2M |
| 2023 | $1.4B | $60.7M | $1.29 | $39.7M |
| 2022 | $1.1B | $45.2M | $0.99 | $59.2M |
| 2021 | $773.9M | $68.9M | $1.52 | $51.1M |
| 2020 | $687.2M | $37.7M | $1.01 | $45M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ASTH ranks in Consumer discretionary
Dividends
It paid out $7.9M in cash dividends, 35% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | n/a | $7.9M | 35% |
| 2024 | n/a | $4M | 9% |
| 2023 | n/a | $62.1M | 102% |
| 2022 | n/a | $14M | 31% |
| 2021 | n/a | $31.1M | 45% |
| 2020 | n/a | $51.3M | 136% |
Latest SEC filings
What Astrana Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 7.1% to $1B versus the same quarter last year; diluted EPS $0.26 versus $0.01.
- November 5, 2026
- October 30, 2026Passive stake changed SCHEDULE 13G/A
- September 23, 2026
- September 23, 2026Cybersecurity incident8-KAstrana Health reported a cybersecurity incident involving unauthorized access to confidential information on its servers.
- September 15, 2026
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 49% to $972.5M versus the same quarter last year; diluted EPS $0.40 versus $0.19.
- August 6, 2026
- July 31, 2026Passive stake (5% or more) SCHEDULE 13G
- July 13, 2026
What is ASTH worth? A DCF from its reported cash flow
Insider trades
What the people running Astrana Health, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 10 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 10, 2026 | Vong JohnSVP - Accounting (PAO) | Shares withheld for tax | 556 | $20.9K |
| October 6, 2026 | Lam Thomas S.Director | Shares withheld for tax | 2,624 | $97.1K |
| October 6, 2026 | Sim BrandonCEO and President | Shares withheld for tax | 9,889 | $365.9K |
| October 2, 2026 | Basho ChandanCOO and CFO | Shares withheld for tax | 2,092 | $75.1K |
| September 15, 2026 | Vong JohnSVP - Accounting (PAO) | Shares withheld for tax | 96 | $3.7K |
| September 5, 2026 | Sim BrandonCEO and President | Shares withheld for tax | 7,163 | $275.6K |
| September 5, 2026 | Basho ChandanCOO and CFO | Shares withheld for tax | 1,790 | $68.9K |
| August 31, 2026 | Kitayama Mitchell WDirector | Other change | 8,500 | $315.3K |
Who owns ASTH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Allied Physicians of California, a Professional Medical Corporation13D, may seek influence | 11% | February 18, 2025 |
| Vanguard Portfolio Management13G, passive | 5.34% | July 31, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 209 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 6,899,990 | +736,263 |
| Vanguard Portfolio Management LLC | 2,605,775 | +328,969 |
| Vanguard Capital Management LLC | 1,946,431 | +236,169 |
| State Street Corp | 1,738,930 | +88,440 |
| 325 Capital LLC | 1,613,843 | -225,233 |
| Dimensional Fund Advisors LP | 1,468,508 | +100,429 |
| Wellington Management Group Llp | 1,292,573 | -49,251 |
| Geode Capital Management, LLC | 1,167,974 | +129,889 |
| Bank of America Corp | 852,145 | +277,416 |
| Fmr LLC | 685,922 | +269,797 |
| Wells Fargo & Company | 664,940 | +561,941 |
| Charles Schwab Investment Management Inc | 652,669 | +8,498 |
| Ameriprise Financial Inc | 512,110 | -39,489 |
| Northern Trust Corp | 505,044 | +66,881 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | 475,941 | -68,093 |
| Royce & Associates LP | 472,480 | +75,519 |
| SteelPeak Wealth, LLC | 464,937 | -95,000 |
| Morgan Stanley | 433,508 | +94,705 |
| Invesco Ltd. | 381,830 | +30,718 |
| Vanguard Fiduciary Trust Co | 307,022 | +14,019 |
Insiders
13 insiders reported holding 3,039,153 shares in total, about $96.8M at the last price.
| Holder | Shares |
|---|---|
| Sim BrandonCEO and President | 1,228,972 |
| Sim Kenneth T.Executive Chairman, Director | 739,407 |
| Lam Thomas S.Director | 463,033 |
| Kumar Dinesh M.Chief Medical Officer | 177,655 |
| Basho ChandanCOO and CFO | 155,728 |
| Dong LindaDirector | 97,133 |
| Mazdyasni MatthewDirector | 39,288 |
| Schmidt DavidDirector | 36,019 |
| Chiang JohnDirector | 35,373 |
| Kitayama Mitchell WDirector | 24,337 |
Questions about ASTH
What does Astrana Health, Inc. do?
Astrana Health, Inc. is a company in the Consumer discretionary sector, listed on NASDAQ as ASTH. Its shares trade on NASDAQ under the ticker ASTH.
What is Astrana Health, Inc.'s net worth?
Astrana Health, Inc. has a market value (market cap) of $1.6B at the latest share price, and shareholders' equity of $856.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Astrana Health, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $53.1M on revenue of $3.9B, a net margin of 1.4%.
How much revenue does Astrana Health, Inc. make?
Over the twelve months to September 30, 2026 Astrana Health, Inc. reported revenue of $3.9B. That is 35.1% more than a year earlier.
When did Astrana Health, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 6, 2026. It covers the period to September 30, 2026.
When is Astrana Health, Inc.'s next earnings report?
Astrana Health, Inc.'s next report is expected around March 1, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare ASTH with
Follow ASTH
Get an email when Astrana Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Astrana Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.